A query last week from an X (formerly Twitter) account called Toka was enough to propel Elon Musk's built in-chatbot called Grok 3 into a viral storm across India's digital landscape. And no, it wasn't some complex math equation or a philosophical debate.

AI platform, Grok, over how it responds to users on the platform. Officials have questioned the way Grok interacts with users and have sought clarity from X on the training and data used to develop the AI.

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 billion in global sales since its initial U.S. launch in 2022.

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. The launch targets the growing obesity and diabetes epidemic in the country, which affects over 101 million people.

US President Donald Trump said he has a “very good relationship” with India, but the “only problem” he has with the country is that it is “one of the .

The broader consensus seems to be that India should capitalise on what could be the unintended consequences of Trump's tariff wars. Pranjul Bhandari, chief India economist at HSBC, believes that "potential US tariffs may have become a catalyst for reforms. ".